Literature DB >> 22829433

Tolerance and sensitization to chronic escalating dose heroin following extended withdrawal in Fischer rats: possible role of mu-opioid receptors.

Katharine M Seip-Cammack1, Brian Reed, Yong Zhang, Ann Ho, Mary Jeanne Kreek.   

Abstract

RATIONALE/
OBJECTIVES: Heroin addiction is characterized by recurrent cycles of drug use, abstinence, and relapse. It is likely that neurobiological changes during chronic heroin exposure persist across withdrawal and impact behavioral responses to re-exposure. We hypothesized that, after extended withdrawal, heroin-withdrawn rats would express behavioral tolerance and/or sensitization in response to heroin re-exposure and that these responses might be associated with altered mu-opioid receptor (MOPr) activity.
METHODS: Male Fischer rats were exposed chronically to escalating doses of heroin (7.5-75 mg/kg/day), experienced acute spontaneous withdrawal and extended (10-day) abstinence, and were re-exposed chronically to heroin. Homecage behaviors and locomotor activity in response to heroin, as well as somatic withdrawal signs, were recorded. Separate groups of rats were sacrificed after extended abstinence and MOPr expression and G-protein coupling were analyzed using [(3)H]DAMGO and [(35)S]GTPγS assays.
RESULTS: The depth of behavioral stupor was lower during the initial days of heroin re-exposure compared to the initial days of the first exposure period. Behavioral responses (e.g., stereotypy) and locomotion were elevated in response to heroin re-exposure at low doses. Rats conditioned for heroin place preference during the chronic re-exposure period expressed heroin preference during acute withdrawal; this preference was stronger than rats conditioned during chronic heroin exposure that followed chronic saline and injection-free periods. Extended withdrawal was associated with increased MOPr expression in the caudate-putamen and frontal and cingulate cortices. No changes in G-protein coupling were identified.
CONCLUSIONS: Aspects of tolerance/sensitization to heroin are present even after extended abstinence and may be associated with altered MOPr density.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22829433      PMCID: PMC3494815          DOI: 10.1007/s00213-012-2801-2

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  92 in total

1.  Immune, neuroendocrine, and somatic alterations in animal models of human heroin abuse.

Authors:  R J Weber; R Gomez-Flores; J E Smith; T J Martin
Journal:  J Neuroimmunol       Date:  2004-02       Impact factor: 3.478

Review 2.  The dynorphin/κ-opioid receptor system and its role in psychiatric disorders.

Authors:  H A Tejeda; T S Shippenberg; R Henriksson
Journal:  Cell Mol Life Sci       Date:  2011-10-16       Impact factor: 9.261

3.  Persistence of chronic morphine effects upon activity in rats 8 months after ceasing the treatment.

Authors:  M Babbini; M Gaiardi; M Bartoletti
Journal:  Neuropharmacology       Date:  1975-08       Impact factor: 5.250

4.  Morphine-induced long-term sensitization to the locomotor effects of morphine and amphetamine depends on the temporal pattern of the pretreatment regimen.

Authors:  L J Vanderschuren; G H Tjon; P Nestby; A H Mulder; A N Schoffelmeer; T J De Vries
Journal:  Psychopharmacology (Berl)       Date:  1997-05       Impact factor: 4.530

5.  Augmented accumbal serotonin levels decrease the preference for a morphine associated environment during withdrawal.

Authors:  G C Harris; G Aston-Jones
Journal:  Neuropsychopharmacology       Date:  2001-01       Impact factor: 7.853

Review 6.  Pharmacogenetics and human molecular genetics of opiate and cocaine addictions and their treatments.

Authors:  Mary Jeanne Kreek; Gavin Bart; Charles Lilly; K Steven LaForge; David A Nielsen
Journal:  Pharmacol Rev       Date:  2005-03       Impact factor: 25.468

7.  Adaptation to prolonged or repeated stress--comparison between rat strains showing intrinsic differences in reactivity to acute stress.

Authors:  F S Dhabhar; B S McEwen; R L Spencer
Journal:  Neuroendocrinology       Date:  1997-05       Impact factor: 4.914

8.  Impaired emotional-like behavior and serotonergic function during protracted abstinence from chronic morphine.

Authors:  Celia Goeldner; Pierre-Eric Lutz; Emmanuel Darcq; Thomas Halter; Daniel Clesse; Abdel-Mouttalib Ouagazzal; Brigitte L Kieffer
Journal:  Biol Psychiatry       Date:  2010-10-14       Impact factor: 13.382

9.  Mechanisms of withdrawal-associated increases in heroin self-administration: pharmacologic modulation of heroin vs food choice in heroin-dependent rhesus monkeys.

Authors:  S Stevens Negus; Kenner C Rice
Journal:  Neuropsychopharmacology       Date:  2008-08-13       Impact factor: 7.853

10.  Modulatory effect of environmental context and drug history on heroin-induced psychomotor activity and fos protein expression in the rat brain.

Authors:  Giovanna Paolone; David Conversi; Daniele Caprioli; Paola Del Bianco; Paolo Nencini; Simona Cabib; Aldo Badiani
Journal:  Neuropsychopharmacology       Date:  2007-03-28       Impact factor: 7.853

View more
  8 in total

1.  Stabilization of morphine tolerance with long-term dosing: association with selective upregulation of mu-opioid receptor splice variant mRNAs.

Authors:  Jin Xu; Andrew J Faskowitz; Grace C Rossi; Mingming Xu; Zhigang Lu; Ying-Xian Pan; Gavril W Pasternak
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-22       Impact factor: 11.205

Review 2.  Mechanism of opioid addiction and its intervention therapy: Focusing on the reward circuitry and mu-opioid receptor.

Authors:  Jia-Jia Zhang; Chang-Geng Song; Ji-Min Dai; Ling Li; Xiang-Min Yang; Zhi-Nan Chen
Journal:  MedComm (2020)       Date:  2022-06-22

3.  Adolescent oxycodone self administration alters subsequent oxycodone-induced conditioned place preference and anti-nociceptive effect in C57BL/6J mice in adulthood.

Authors:  Yong Zhang; Kyle Windisch; Joshua Altschuler; Sage Rahm; Eduardo R Butelman; Mary Jeanne Kreek
Journal:  Neuropharmacology       Date:  2016-09-07       Impact factor: 5.250

4.  Extended access oxycodone self-administration and neurotransmitter receptor gene expression in the dorsal striatum of adult C57BL/6 J mice.

Authors:  Yong Zhang; Brandan Mayer-Blackwell; Stefan D Schlussman; Matthew Randesi; Eduardo R Butelman; Ann Ho; Jurg Ott; Mary Jeanne Kreek
Journal:  Psychopharmacology (Berl)       Date:  2013-11-13       Impact factor: 4.530

5.  Neural correlates of adherence to extended-release naltrexone pharmacotherapy in heroin dependence.

Authors:  A-L Wang; I Elman; S B Lowen; S J Blady; K G Lynch; J M Hyatt; C P O'Brien; D D Langleben
Journal:  Transl Psychiatry       Date:  2015-03-17       Impact factor: 6.222

6.  Behavioral flexibility and response selection are impaired after limited exposure to oxycodone.

Authors:  Katharine M Seip-Cammack; Matthew L Shapiro
Journal:  Learn Mem       Date:  2014-11-17       Impact factor: 2.460

Review 7.  Sugar addiction: the state of the science.

Authors:  Margaret L Westwater; Paul C Fletcher; Hisham Ziauddeen
Journal:  Eur J Nutr       Date:  2016-07-02       Impact factor: 5.614

Review 8.  Cannabis Addiction and the Brain: a Review.

Authors:  Amna Zehra; Jamie Burns; Christopher Kure Liu; Peter Manza; Corinde E Wiers; Nora D Volkow; Gene-Jack Wang
Journal:  J Neuroimmune Pharmacol       Date:  2018-03-19       Impact factor: 4.147

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.